首页> 外文期刊>Tropical Animal Health and Production >Serological and molecular investigation for brucellosis in swine in selected districts of Uganda
【24h】

Serological and molecular investigation for brucellosis in swine in selected districts of Uganda

机译:乌干达部分地区猪布鲁氏菌病的血清学和分子学研究

获取原文
获取原文并翻译 | 示例
           

摘要

Brucellosis is a notifiable zoonotic disease affecting livestock, humans, and wildlife in Uganda. Pigs can be infected with human pathogenic Brucella suis biovars 1 and 3 and can be a significant source of brucellosis for humans. Uganda has a rapidly growing pig population, and the pork consumption per capita is the highest in East Africa. The objective of this work was to determine the seroprevalence of brucellosis in Ugandan pigs. A cross-sectional serosurvey of pigs was conducted in three of the major pig-keeping districts in Uganda (Masaka (n = 381 samples), Mukono (n = 398), and Kamuli (n = 414)). In addition, pigs originating from these districts were sampled in the major pig abattoir in Kampala (n = 472). In total, 1665 serum samples were investigated by serological and molecular tests. Only three putative brucellosis-positive samples were detected serologically using indirect ELISA. These sera were found negative for Brucella antibodies by CFT; however, two had antibodies against Yersinia enterocolitica as determined by SAT. Presence of antibodies against Yersiniae was confirmed by Y. enterocolitica antibody-specific ELISA. The two Yersiniae ELISA-positive samples were brucellosis negative using real-time PCR. We tested additional 142 sera from the 1665 samples with real-time PCR. All tested negative. Under this type of production system, we expect a maximum B. suis prevalence of less than 1 % at 95 % confidence level, and therefore, the risk of acquiring brucellosis from the pigs or their products is negligible. However, pigs may harbor the zoonotic Y. enterocolitica. This is the first study to investigate the occurrence of brucellosis in pigs in Uganda and the first study to report Y. enterocolitica antibodies in swine in Uganda.
机译:布鲁氏菌病是一种应通报的人畜共患病,影响乌干达的牲畜,人类和野生动植物。猪可能感染了人类致病性猪布鲁氏菌生物变种1和3,可能是人类布鲁氏菌病的重要来源。乌干达的生猪数量迅速增长,人均猪肉消费量是东非最高的。这项工作的目的是确定乌干达猪中布鲁氏菌病的血清阳性率。在乌干达的三个主要养猪区(马萨卡(n = 381个样本),穆科诺(n = 398)和卡穆利(n = 414))进行了猪的横断面血清调查。此外,在坎帕拉(n = 472)的主要猪屠宰场对这些地区的猪进行了采样。总共通过血清学和分子测试研究了1665个血清样本。使用间接ELISA在血清学上仅检测到三个假定的布鲁氏菌病阳性样品。通过CFT发现这些血清对布鲁氏菌抗体呈阴性。然而,根据SAT的测定,其中两个具有针对小肠结肠炎耶尔森氏菌的抗体。肠球菌耶尔森氏菌特异性ELISA证实了针对耶尔森氏菌的抗体的存在。使用实时PCR,两个耶尔森氏菌ELISA阳性样品均为布鲁氏菌病阴性。我们通过实时PCR检测了1665个样品中的另外142个血清。所有测试均为阴性。在这种类型的生产系统下,我们预期在95%置信水平下最大的猪链球菌流行率小于1%,因此,从猪或其产品中获得布鲁氏菌病的风险可以忽略不计。但是,猪可能带有人畜共患的小肠结肠炎耶尔森氏菌。这是乌干达第一项调查猪布鲁氏菌病发生的研究,也是乌干达首例报告猪小肠结肠炎耶尔森氏菌抗体的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号